Thrombolytic Science is focused on developing a proprietary product, M5, a mutant of pro-urokinase (proUK). M5 is a thrombolytic that follows a different paradigm than tPA, has superior efficacy and is accompanied by little bleeding risk.

Part of Tasly Pharmaceutical Group Co., Ltd., Shanghai Tasly Pharmaceutical Co. Ltd. is a Chinese company located in Shanghai. The firm manufactures and sells pharmaceutical products. Tasly Pharmaceutical Group Co., Ltd. acquired Shanghai Tasly Pharmaceutical Co. Ltd. on July 12, 2007 for $1.53 million.

Gruppo Lepetit SRL, part of Sanofi, is a company headquartered in Italy. The firm manufactures pharmaceuticals and proprietary medicines, medical and surgical supplies.

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Part of Novartis AG, Sandoz AG is a Swiss company located in Basel. The firm develops generic medicines and biosimilars.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

ProteomTech, Inc. is an American private company located in Emeryville, CA, that develops protein therapeautics.

Rin Institute, Inc. is a Japanese company located in Tokyo that develops antibody medicine for the diagnosis and treatment of cancer. It was founded in 2016 by Kentaro Yoshimatsu.

GemPharmatech is a high-tech biotechnology enterprise specializing in the research and development of humanized models and drug screening technologies. It has a leading disease model research and development ability and a genetic engineering mouse model creation center.In 2018, the company's "Humanization Model and Drug Screening Innovation Technology Research Institute" was absorbed by the Jiangsu Industrial Technology Research Institute as a "professional research institute", and became a new research and development institution that supports the establishment of an industrial chain and international development in this field. The company aims to provide global partners with one-stop innovative technologies and resource services such as model creation, breeding, mouse sales, phenotypic analysis, and functional efficacy.

Farmitalia Carlo Erba

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Cerbios specializes in the development and manufacture of chemical and biological APIs. They provide contract development and manufacturing operation services for high-potency active pharmaceutical ingredients, recombinant proteins, and antibody drug conjugates, from preclinical to commercial supply. They also provide drug substances, animal health, and drug products.

Jiangsu Eureka Biotechnology Co., Ltd., established on 2005-10-17, Business scope includes pharmaceutical intermediates(Does not contain dangerous goods)Development,production and sales;Seedling planting and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Weitongda Biotechnology Co., Ltd., established on 2000-06-27, Business scope includes general cargo;breeding laboratory animals;Provide technical consultation for self-produced products,Technical Services,technology transfer;Sell ​​self-produced products;Import and export,Technology Import and Export,Agent import and export;Office space for rent,commercial space;(Commodities that do not involve state trade management;For commodities subject to quota license management, the application procedures shall be handled in accordance with relevant state regulations).((The enterprise was2003year09moon04Currently a domestic enterprise,At2003year09moon04The day changed to a Sino-foreign joint venture market subject to independently choose operating projects in accordance with the law,Carry out business activities,General cargo and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments.))

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.